Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Accidental administration of Infanrix instead of Boostrix.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 46-year-old female patient who received DTPa (Infanrix) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 16-APR-2025, the patient received Infanrix. On an unknown date, the patient received Boostrix. On 16-APR-2025, an unknown time after receiving Infanrix and not applicable after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: Accidental administration of Infanrix instead of Boostrix.). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 01-MAY-2025 The nurse practitioner called to inform that, a patient accidentally received a dose of Infanrix. According to reporter, the initial intention was to administer a booster dose of Boostrix, which led to wrong vaccine administered.